We showed that PARP1 mRNA expression is heterogeneous in STS and associated with metastatic relapse independently from the other prognostic features, including the proliferation‐associated CINSARC signature, the most robust prognostic signature reported to date in STSs. This evidence concerns the gene PARP1 and telomere syndrome.